SAM
ANIP icon

Senzar Asset Management’s ANI Pharmaceuticals ANIP Stock Holding History

Senzar Asset Management’s Portfolio ANIP Stock Details ANIP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q2 		– Sell
-223,871
Closed -$7.54M – 42
2016
Q1 		$7.54M Sell
223,871
-229,981
-51% -$7.8M 1.5% 22
2015
Q4 		$20.5M Buy
453,852
+183,812
+68% +$7.91M 2.28% 13
2015
Q3 		$10.7M Buy
+270,040
New +$15.4M 1.55% 18

Other funds holding ANIP

CCM
Consonance Capital Management New York $7.28M AUM 43.59% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
HVC
Healthcare Value Capital Woodcliff Lake, New Jersey $50.7M AUM 24.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Allianz Asset Management
Allianz Asset Management Munich, Germany $112B AUM 36.28% 1-Year Est. Return
Fiera Capital (Canada)
Fiera Capital (Canada) Montreal, Quebec, Canada $27.6B AUM 23.56% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Nomura Holdings
Nomura Holdings Tokyo, Japan $85.4B AUM 91.09% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Senzar Asset Management's ANIP Position: Q2 2016 in Review

Senzar Asset Management sold out of ANI Pharmaceuticals (ANIP) in Q2 2016, closing a stake of 223,871 shares — an estimated $7.54M sold.

Senzar Asset Management first reported a position in ANIP in Q3 2015 and held it in 3 quarters. The position peaked at $20.5M in Q4 2015. 138 funds tracked by Wall St. Rank hold ANIP as of Q2 2016.

  • Senzar Asset Management reported no remaining ANI Pharmaceuticals position as of Q2 2016 after selling out during the quarter.
  • Senzar Asset Management sold 223,871 ANI Pharmaceuticals shares in Q2 2016, an estimated $7.54M.
  • Senzar Asset Management first reported a position in ANI Pharmaceuticals in Q3 2015 and held it in 3 quarters.
  • Senzar Asset Management's ANI Pharmaceuticals position peaked at $20.5M in Q4 2015.
  • 138 funds tracked by Wall St. Rank held ANI Pharmaceuticals as of Q2 2016.

Based on Senzar Asset Management's 13F filing for Q2 2016, filed 12 Aug 2016.